PI3K Pathways in Immunology, Growth Disorders and Cancer
Organizer(s): Leon O. Murphy, Klaus Okkenhaug and Sabina C. CosulichDate: January 19 - 23, 2017
Location: Hilton Santa Fe Historic Plaza Hotel, Santa Fe, NM, USA
The overall goal for this meeting is to bring together scientific leaders and trainees with a common interest in PI3Ks and relevant downstream physiological processes. It will address advances in basic molecular and cellular mechanisms that are regulated by PI3Ks, other PI kinases and, their cognate phosphatases; highlight new advances in the characterization of PI3K pathway alterations in genetic syndromes that affect growth and the immune and nervous systems; and provide an important update on the clinical development of PI3K pathway inhibitors, and implications for the burgeoning field of cancer immunotherapy. Whole exome sequencing studies have increasingly implicated PI3K signaling in diseases (immune, growth and neurological disorders) which may benefit from drugs currently in development for cancer and inflammation. This meeting will be an important forum for discussing approaches to treating these additional disorders.
Scholarship Deadline: September 21 2016
Discounted Abstract Deadline: September 21 2016
Abstract Deadline: October 19 2016
Discounted Registration Deadline: November 16 2016
We gratefully acknowledge additional support for this conference from:
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:
Cell Signaling Technology, Inc.
Novartis Institutes for BioMedical Research
Third Rock Ventures